<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23812531</identifier>
<setSpec>1678-2925</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cumsille, Cristián</dc:author>
<dc:author>Mellado, Felipe</dc:author>
<dc:author>Rojas, Tomás</dc:author>
<dc:description xml:lang="en">Fungal keratitis is a characteristic infection upon tropical zones, associated with vegetal trauma. Doubt exists about the best diagnostic test and the effectiveness of available treatment. Which is the best diagnostic method for fungal keratitis? And, which is the best management? Fungal culture remains as diagnostic gold standard of fungal elements. As of treatment, natamycin and amphotericin B are the most popular drugs for fungal keratitis and they have not shown effectiveness in randomized controlled trials or systematic reviews. Voriconazole showed effectiveness and security in multiple fungal infections. It may be the drug of choice in optimal conditions, because of its better ocular penetration and wider coverage. However, its high price difficult general application. This review establishes management recommendations and the need to perform studies that address cost-effectiveness analysis of voriconazole for fungal keratitis.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Jan-Feb </dc:date>
<dc:title xml:lang="es">Queratitis fúngica: revisión actual sobre diagnóstico y tratamiento.</dc:title>
<dc:title xml:lang="en">[Fungal keratitis: review of diagnosis and treatment].</dc:title>
<dc:publisher>Arquivos brasileiros de oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
